Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteers.
Br J Clin Pharmacol
; 88(2): 865-870, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34327739
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatitis
/
Kynurenine
Type of study:
Clinical_trials
Limits:
Humans
/
Male
Language:
En
Year:
2022
Type:
Article